This study aimed to elucidate whether ASPP2 can decrease triglyceride (TG) accumulation and to clarify the relationship between ASPP2, apoptosis and autophagy in NAFLD. Here, TP53BP2 is linked to metabolic dysfunction-associated steatotic liver disease.